Canadian firm Valeant Pharmaceuticals International is to buy Bausch + Lomb in an $8.7 billion deal which will see the …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

